Brian T. Helfand, MD, PhD, presented “Therapeutic Modalities for BPH” during the 34th International Prostate Cancer Update on February 12, 2024, in Vail, Colorado.
This content is available free to the GRU Community. Login or create an account to view it.
How to cite: Helfand, Brian T. “Therapeutic Modalities for BPH.” February 2024. Accessed Nov 2024. https://grandroundsinurology.com/therapeutic-modalities-for-bph/
Therapeutic Modalities for BPH – Summary
Brian T. Helfand, MD, PhD, explores therapeutic modalities to prevent non-compliance in patients with Benign Prostatic Hyperplasia (BPH). He begins by establishing the pattern of medication-based non-compliance in BPH patients due to the impact on sexual function, and the evolution of BPH management.
Dr. Helfand then discusses recent technologies for BPH management that preserve sexual function. He presents current options for surgical intervention for BPH, ranging from minimally-invasive surgical therapies to prostatectomies. For each option, he explores the treatment’s durability and impact on quality of life.
Dr. Helfand concludes by presenting resources to help urologists and patients choose the most appropriate treatment modality for their individual cases. He emphasizes the importance of involving the patient in the decision-making process in order to ensure compliance.
About The 34th Annual International Prostate Cancer Update:
The International Prostate Cancer Update (IPCU), founded in 1990, is a multi-day CME conference focused on prostate cancer treatment updates with expert, international faculty. It is led by expert physicians and is designed for urologists, medical oncologists, radiation oncologists, and other healthcare professionals involved in the diagnosis and treatment of prostate cancer. The 34th iteration of the meeting occurred February 11-14, 2024 in Vail, Colorado. To view more educational presentations from IPCU 34, visit our collection page.
